Abstract: A system for configuring unmanned aircraft system (UAS) to a structure is disclosed. The structure may be a standing structure such as a tower. A movement system may be configured with the tower. The UASs may be tethered to the movement structure and the movement structure may move with respect to the tower.

Abstract: A system and method for altering the visual appearance of moving physical forms is disclosed. The moving physical forms may include solids, liquids, gasses and any combination thereof. The system and method may include video capturing devices for capturing video footage of the moving forms, a controller for altering the captured video footage of the moving forms, and video projecting devices for projecting the altered video footage back onto the moving forms.

Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: A fire display that may reside under a viewing window or panel. The display may include a tray or channel along which a fire ball or fire wave may travel. The display includes a gas delivery system.

Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Abstract: A system for configuring unmanned aircraft system (UAS) to a structure is disclosed. The structure may be a standing structure such as a tower. A movement system may be configured with the tower. The UASs may be tethered to the movement structure and the movement structure may move with respect to the tower.

Abstract: A system for providing a flying craft is disclosed. The craft may include gyroscopes for stability, and rotor blades and/or chambers of lighter-than-air gasses for lift. The craft may be equipped with payloads such as lights, water delivery devices, speaker, wireless power systems and other payloads.

Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Abstract: The present disclosure relates to certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Abstract: A fire display that may reside under a viewing window or panel. The display may include a tray or channel along which a fire ball or fire wave may travel. The display includes a gas delivery system.

Abstract: A water display including a number of pixels or manifolds that may include water nozzles to emit streams of water and/or other utilities such as lighting is described. The water streams may be pixelated so as to provide a high resolution waveform or other choreography. The choreography transitions between waveforms to provide the appearance of a cascading or undulating wave. A tool to design the water display and simulate its appearance is also described.

Abstract: Described herein are filter assemblies for removing high molecular weight organic components from liquefied petroleum gas, as well as methods for removing high molecular weight components from liquefied petroleum gases. The filter assemblies include an upstream carbon-containing filter media pack and a downstream filter media pack.

Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.

Abstract: A multi-phase switching power converter includes a panic mode detector that triggers the activation of each phase in an open-loop mode of operation in which an open-loop duty cycle is used that is greater than a closed-loop duty cycle used during closed-loop operation for the active phases.

Abstract: A method for connecting a number of users with at least one signal bearing optical fiber (1101÷z; 2101÷5) contained in an optical cable (105; 205) is proposed.

Abstract: A new and distinct variety of fig (Ficus carica) tree named ‘4-19’, characterized by its large size and dark purple skin, as well as its productivity and regular bearing. The tree produces two crops, both the breba first crop and the productive second, or main, crop. The fruit eye is usually small, the fruit skin and meat are moderately thick and durable, and the fruit pulp has an attractive reddish color, is fine-textured, and is sweet and rich in flavor. The fruit appears to hold its size later into the season than other commercial varieties of figs, thus extending the season for prime size and quality figs.